Liezl Gambe

Reserve Bank of Australia governor Michele Bullock has joined a group of leading central bankers in publicly backing US Federal Reserve chair Jerome Powell.

Polygon Labs announced the acquisition of Coinme and Sequence in a combined deal valued at $250 million, marking a strategic shift towards becoming a regulated payments-focused company.

The U.S. Consumer Price Index (CPI) rose at an annual rate of 2.7% in December 2025, matching the previous month’s pace and signaling that the long-awaited "last mile" to the Federal Reserve’s 2% target remains elusive.

Fortress Biotech Inc. (Nasdaq: FBIO) and its majority-owned subsidiary, Cyprium Therapeutics, secured a historic regulatory victory Tuesday as the U.S. Food and Drug Administration approved ZYCUBO® (copper histidinate) as the first-ever treatment for Menkes disease.

Sight Sciences (NASDAQ:SGHT), a leader in interventional eyecare technologies, released preliminary fourth-quarter 2025 results on Jan. 13, showing a return to growth driven by its interventional dry eye business.

Armata Pharmaceuticals (NYSE:ARMP) is poised to become the first company to advance a bacteriophage candidate into a Phase 3 clinical trial, following a positive End-of-Phase 2 (EOP2) response from the U.S. Food and Drug Administration (FDA).

Kestra Medical Technologies (NASDAQ:KMTS) has announced a strategic collaboration and exclusive co-development agreement with Biobeat Technologies to integrate advanced hemodynamic monitoring into its cardiac recovery platform.

Bitcoin is facing a fresh test as a public feud between President Trump and the Federal Reserve escalates.

A report says UK-registered crypto firms helped move billions in digital assets linked to Iran’s military organisation.

China and the European Union have agreed on measures aimed at easing tensions over Chinese electric vehicle imports.